|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 263.84 USD | -2.16% |
|
-8.34% | -10.13% |
| 08-01 | UCB SA, H1 2026 Earnings Call, Jul 30, 2026 | |
| 07-31 | AlphaValue/Baader Europe Upgrades UCB to Add, Trims PT | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 76.15B | |||||
| 47.83B | |||||
| 41.37B | - | ||||
| 29.99B | |||||
| 24.23B |
- Stock Market
- Stocks
- UCB Stock
- UCBJF Stock
- Charts UCB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
